Stay updated on Daratumumab in Renal-Impaired Myeloma: Efficacy Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in Renal-Impaired Myeloma: Efficacy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in Renal-Impaired Myeloma: Efficacy Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page revision was updated from v3.4.0 to v3.4.1, with no visible content changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T10:17:00.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Added a glossary display option and new labels such as 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', and introduced a 'No FEAR Act Data' notice. The older items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.
    Difference
    0.2%
    Check dated 2026-01-28T06:00:30.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Deleted the Statistical Analysis Plan (2018-02-02, 2.35MB) and the Study Protocol (2020-06-08, 1.12MB) from the study documents.
    Difference
    19%
    Check dated 2026-01-21T03:23:37.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The page shows a minor site revision update from v3.3.3 to v3.3.4 (UI changes) with no impact on study content or functionality; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:48:34.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Added a Locations section with Attica as a study site and updated the page revision to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T14:28:03.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    Publications section wording was updated to clarify automatic population from PubMed (and related notifications), and the revision label changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:54:12.000Z thumbnail image

Stay in the know with updates to Daratumumab in Renal-Impaired Myeloma: Efficacy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in Renal-Impaired Myeloma: Efficacy Clinical Trial page.